The bronchiectasis market is expected to experience steady growth, with a strong CAGR projected from 2024 to 2034. This growth in the 7MM will be fueled by the launch of new treatments like ...
Sep. 24—(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 adults nationwide, is necessary to slow disease progression and help ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio New data from the BEST-1 trial indicated ...
Bronchiectasis is a chronic condition of the respiratory system, in which there is abnormal widening of the airways due to an initial damaging factor. This in turn reduces the ability of the bronchi ...
Bronchiectasis is a chronic condition of the respiratory system that is due to abnormal widening of the airways as a consequence of an initial damaging factor. The bronchi, located between the trachea ...
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Bronchiectasis - Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This report ...
Panelists discuss how emerging DPP1 inhibitor therapies target neutrophil serine proteases to reduce neutrophilic inflammation and neutrophil extracellular trap formation in bronchiectasis. DPP1 ...
PHILADELPHIA (WPVI) -- A cough can be a mild irritant or a signal of something more serious, especially when it stretches for weeks on end. When you have a cough that lasts for some time it is ...
BRONCHIECTASIS is protean in its expressions as it is sometimes obscure in its origin. The clinical picture varies in individual patients, but common to the severer cases is a history of harassing, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results